Eiken Chemical Co Ltd
TSE:4549
Intrinsic Value
Eiken Chemical Co., Ltd. engages in the manufacture and sale of clinical diagnostics products and equipment. [ Read More ]
The intrinsic value of one
Eiken Chemical Co Ltd
stock under the Base Case scenario is
1 690.93
JPY.
Compared to the current market price of 1 935 JPY,
Eiken Chemical Co Ltd
is
Overvalued by 13%.
Eiken Chemical Co Ltd's market capitalization is 71.8B JPY.
Eiken Chemical Co Ltd stock price is 1 935 JPY.
Eiken Chemical Co Ltd stock (1 690.93 JPY) is 13% less than its price (1935 JPY).
Eiken Chemical Co Ltd stock (1 794.12 JPY) is 7% less than its price (1935 JPY). Open DCF Valuation
Eiken Chemical Co Ltd stock (1 587.73 JPY) is 18% less than its price (1935 JPY). Open Relative Valuation
Eiken Chemical Co Ltd has downside potential of 6% compared to the average analyst price target.
Open Wall St Estimates
Eiken Chemical Co Ltd's Revenue is forecast to grow at a rate of 2% per year over the next 3 years.
Eiken Chemical Co Ltd's Revenue has been growing by 2% per year for the last 3 years.
Eiken Chemical Co Ltd's ROIC (Return on Invested Capital) for the past 12 months is positive and is equal to 7%.
Eiken Chemical Co Ltd has positive Net Income for the last twelve months.
Eiken Chemical Co Ltd has positive three-year average ROE (Return on Equity): 12%. The company is efficient at transforming stockholders' equity into net income.
Eiken Chemical Co Ltd's ROE (Return on Equity) for the past 12 months is positive and is equal to 6%.
Eiken Chemical Co Ltd's ROIC (Return on Invested Capital) has decreased in the last 3 years from 13% to 7%.
Eiken Chemical Co Ltd's ROE (Return on Equity) has decreased in the last 3 years from 13% to 6%.
Eiken Chemical Co Ltd has positive Operating Income for the last twelve months.
Eiken Chemical Co Ltd has positive three-year average ROIC (Return on Invested Capital): 14%. The company is efficient at using invested capital to generate operating income.
Eiken Chemical Co Ltd's Revenue has dropped by 11% over the past 12 months.
Eiken Chemical Co Ltd has positive Free Cash Flow for the last twelve months.
Eiken Chemical Co Ltd has positive Gross Profit for the last twelve months.
Eiken Chemical Co Ltd's short-term assets (40B JPY) exceed its short-term liabilties (11B JPY).
Eiken Chemical Co Ltd's D/E (Debt to Equity) is very low and is equal to 0.06.
Eiken Chemical Co Ltd's long-term assets (65B JPY) exceed its long-term liabilties (15B JPY).
Eiken Chemical Co Ltd has negative Net Debt. This means that the company has more cash and short-term investments (18B JPY) than debt (3B JPY).
Eiken Chemical Co Ltd's Altman Z-Score is very high and is equal to 4.36.
Eiken Chemical Co Ltd earns more than enough operating income (4B JPY) to safely cover interest payments on its debt (17m JPY).
Valuation Backtest
Eiken Chemical Co Ltd
Run backtest to discover the historical profit from buying and selling
Eiken Chemical Co Ltd
stocks based on their intrinsic value.
Analyze the historical link between intrinsic value and market price to make more informed investment decisions.
Fundamental Analysis
Eiken Chemical Co Ltd
Balance Sheet Decomposition
Eiken Chemical Co Ltd
| Current Assets | 39.7B |
| Cash & Short-Term Investments | 17.7B |
| Receivables | 12.6B |
| Other Current Assets | 9.3B |
| Non-Current Assets | 25.5B |
| PP&E | 16.9B |
| Intangibles | 860m |
| Other Non-Current Assets | 7.7B |
| Current Liabilities | 10.6B |
| Accounts Payable | 7.8B |
| Accrued Liabilities | 321m |
| Other Current Liabilities | 2.4B |
| Non-Current Liabilities | 4.3B |
| Long-Term Debt | 3B |
| Other Non-Current Liabilities | 1.3B |
Earnings Waterfall
Eiken Chemical Co Ltd
|
Revenue
|
39.9B
JPY
|
|
Cost of Revenue
|
-22.9B
JPY
|
|
Gross Profit
|
17B
JPY
|
|
Operating Expenses
|
-13.2B
JPY
|
|
Operating Income
|
3.9B
JPY
|
|
Other Expenses
|
-930m
JPY
|
|
Net Income
|
2.9B
JPY
|
Free Cash Flow Analysis
Eiken Chemical Co Ltd
What is Free Cash Flow?
Profitability Score
Profitability Due Diligence
Eiken Chemical Co Ltd's profitability score is 53/100. The higher the profitability score, the more profitable the company is.
Score
Eiken Chemical Co Ltd's profitability score is 53/100. The higher the profitability score, the more profitable the company is.
Solvency Score
Solvency Due Diligence
Eiken Chemical Co Ltd's solvency score is 96/100. The higher the solvency score, the more solvent the company is.
Score
Eiken Chemical Co Ltd's solvency score is 96/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
Price Targets Summary
Eiken Chemical Co Ltd
According to Wall Street analysts, the average 1-year price target for
Eiken Chemical Co Ltd
is 1 810.5 JPY
with a low forecast of 1 717 JPY and a high forecast of 1 942.5 JPY.
Shareholder Return
Price
Eiken Chemical Co Ltd
| Average Annual Return | -6.79% |
| Standard Deviation of Annual Returns | 9.58% |
| Max Drawdown | -42% |
| Market Capitalization | 71.8B JPY |
| Shares Outstanding | 34 597 892 |
| Percentage of Shares Shorted |
N/A
|
Company Profile
Eiken Chemical Co Ltd
Country
Industry
Market Cap
Dividend Yield
Description
Eiken Chemical Co., Ltd. engages in the manufacture and sale of clinical diagnostics products and equipment. The company is headquartered in Taito-Ku, Tokyo-To and currently employs 733 full-time employees. Through its subsidiaries, the Company involves in the processing, manufacture, purchase and sale of test agents. The products and services include microbial testing reagents, urine testing reagents, immunoserologic testing reagents, biochemical testing reagents and instrument food environment-related media.
Contact
IPO
Employees
Officers
The intrinsic value of one
Eiken Chemical Co Ltd
stock under the Base Case scenario is
1 690.93
JPY.
Compared to the current market price of 1 935 JPY,
Eiken Chemical Co Ltd
is
Overvalued by 13%.
You don't have any saved screeners yet
